From code to cure: Harnessing AI for antibiotic discovery and design
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Here, we survey recent advances in AI for both small-molecule and peptide antimicrobial drugs, highlight emerging data and reporting standards, and outline translational pathways and regulatory hurdles needed to bring these agents to patients.
Appeared: Friday, October 16. Science Translational Medicine. Peer-reviewed journal.